[1] |
TANG Mufei, SHEN Yunzhu, ZHANG Baoguo.
Influence of CYP2D6 gene polymorphism on the effect of tropisetron in preventing chemotherapy induced nausea and vomiting
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 817-822.
|
[2] |
WAN Ping, LIU Liang, ZHANG Ping, ZHANG Zhongdong.
Influential factors of serum concentration/dosage ratio for schizophrenia patients after oral administration of olanzapine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(9): 1024-1029.
|
[3] |
WANG Ente, ZHANG Xiaodan, ZHOU Shuang, ZHAO Xia, ZHOU Ying, CUI Yimin.
Effects of genetic polymorphisms on metabolic kinetics, pharmacodynamics and adverse reactions of amitriptyline
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(2): 235-240.
|
[4] |
HUANG Xinyi, GUO Fei, ZENG Xiangchang, OUYANG Dongsheng.
Short-chain fatty acids as signal molecules in intestinal inflammation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(11): 1293-1299.
|
[5] |
ZHOU Jianhua, LIU Kelan, WU Ganbin.
Effects of anti-platelet individual treatment guided by CYP2C19 polymorphism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1364-1367.
|
[6] |
WANG Chanyue, WANG Ye, ZHANG Peipei, CHEN Mingyue, YANG Hao, ZHU Manli, LI Linlin.
Relationship of Fusobacterium nucleatum levels in gut microbiota with type 2 diabetes mellitus in Uygurs of Xinjiang
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1321-1325.
|
[7] |
WANG Ying-ying, CHENG Guang-hua, PU Zhi-chen, GE Jun-liang, XIE Yan, CHEN Xiao-lei.
Association between CYP2D6*10/CYP2C19*2 genotype polymorphism and survival of breast cancer patients receiving tamoxifen treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 552-556.
|
[8] |
LI Xiao-ning, YANG Zheng-hai, LI Jing.
Study of different genotypes hepatitis C virus non-structural 3 protein on telomerase activity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 128-131.
|
[9] |
LI Tai-lin, XIE Hai-tang, XU Biao-bo, PENG Yan, WAN Zi-rui, SUN Hong, ZENG Ying, SHEN Jie, WANG Guo, ZHU Yuan-shan.
Genotyping of ABCG2 34G>A polymorphism by allele-specific PCR
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1111-1115.
|
[10] |
SHEN Jie, XIE Hai-tang, LIU Zhao-qian.
Translation initiation factors and abnormalities of translation control in tumors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 331-338.
|
[11] |
CHENG Yuan-guang, WU Pei.
Expression of somatostatin receptor type 2 in colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(10): 1100-1104.
|
[12] |
CHEN Bing, CAI Wei-min, YANG Wan-hua.
Genetic polymorphism of CYP2D6 and its influence on the personalized usage of antipsychotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1067-1074.
|
[13] |
XIONG Dan, XIONG Yu-qing.
Polymorphism of CYP2D6 gene and the influence on the metabolism of metoprolol
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1059-1064.
|
[14] |
WU Hui-zi, LIU Jie.
Pharmacogenetics in breast cancer: hormone therapy and chemotherapy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(3): 334-340.
|
[15] |
SHI Liang-hui, ZHANG Cai-quan, PENG Xiao-zhuang.
Relationship between the expression of LAT1,CD98hc and clinical pathological characteristics of gastric carcinoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(12): 1361-1366.
|